购物车
- 全部删除
- 您的购物车当前为空
HBX 19818 是一种特异性泛素特异性蛋白酶 7 (USP7) 抑制剂,IC50值为 28.1 μM。
为众多的药物研发团队赋能,
让新药发现更简单!
HBX 19818 是一种特异性泛素特异性蛋白酶 7 (USP7) 抑制剂,IC50值为 28.1 μM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 297 | 现货 | |
5 mg | ¥ 942 | 现货 | |
10 mg | ¥ 1,530 | 现货 | |
25 mg | ¥ 2,550 | 现货 | |
50 mg | ¥ 3,550 | 现货 | |
100 mg | ¥ 4,970 | 现货 | |
200 mg | ¥ 6,680 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 987 | 现货 |
产品描述 | HBX 19818 is a specific ubiquitin-specific protease 7 (USP7) inhibitor (IC50: 28.1 μM). |
靶点活性 | USP7:28.1 μM |
体外活性 | HBX 19818 inhibits HCT116 proliferation in a dose-dependent manner (IC50: ~2 μM). HBX 19818 selectively inhibits USP7 (IC50: ~6 μM in human cancer cells). HBX 19818 (1.5, 4, 12, 36, or 100 μM) inhibits USP7 deubiquitination of polyubiquitinated p53. HBX 19818 displays no effects on USP8, USP5, USP10, CYLD, UCH-L1, UCH-L3, or on SENP1, a SUMO protease (IC50s of > 200 μM). HBX 19818 (30 μM) also causes significantly higher levels of Mdm2 polyubiquitinated forms in USP7-overproducing HEK293 cells than those in DMSO-treated control cells. |
分子量 | 421.96 |
分子式 | C25H28ClN3O |
CAS No. | 1426944-49-1 |
Smiles | CN(CCCNC(=O)c1ccc2nc3CCCCc3c(Cl)c2c1)Cc1ccccc1 |
密度 | 1.206 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
溶解度信息 | DMSO: 20 mg/mL (47.40 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容